-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Raises Price Target on Integra LifeSciences to $59 From $50, Reiterates Equalweight Rating

Morgan Stanley Raises Price Target on Integra LifeSciences to $59 From $50, Reiterates Equalweight Rating

MT Newswires · 01/06/2023 05:11